Review
Published on 15 Jan 2024
Diagnosis, treatment, and prognosis of stage IB non-small cell lung cancer with visceral pleural invasion
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1310471
- 3,051 views
- 3 citations
- Frontiers in Oncology
- Thoracic Oncology
- Articles
Type at least 3 characters
1,599 articles
Articles
Case Report
Published on 12 Jan 2024
Primary mediastinal Ewing’s sarcoma presenting with sudden and severe chest pain: a case report
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1290603
- 1,030 views
Original Research
Published on 11 Jan 2024
Cost-effectiveness analysis of serplulimab combination therapy versus chemotherapy alone for patients with extensive-stage small cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1259574
- 1,361 views
- 2 citations
Systematic Review
Published on 11 Jan 2024
Non-small cell lung cancer with MET amplification: review of epidemiology, associated disease characteristics, testing procedures, burden, and treatments
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1241402
- 4,797 views
- 3 citations
Original Research
Published on 10 Jan 2024
Cerebrospinal fluid ctDNA testing shows an advantage over plasma ctDNA testing in advanced non-small cell lung cancer patients with brain metastases
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1322635
- 1,741 views
Perspective
Published on 10 Jan 2024
Perspective: rethinking therapeutic strategies in oncology
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1335987
- 1,072 views
Original Research
Published on 09 Jan 2024
ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 and sensitizes EML4-ALK variant 3 to crizotinib
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1281510
- 1,685 views
Original Research
Published on 09 Jan 2024
Molecular epidemiology study of programmed death ligand 1 and ligand 2 protein expression assessed by immunohistochemistry in extensive-stage small-cell lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1225820
- 1,185 views
Systematic Review
Published on 09 Jan 2024
Primary pulmonary nuclear protein of the testis midline carcinoma: case report and systematic review with pooled analysis
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1308432
- 1,312 views
Opinion
Published on 09 Jan 2024
The great need to overcome osimertinib resistance in advanced non-small cell lung cancer: from combination strategies to fourth-generation tyrosine kinase inhibitors
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1308460
- 2,923 views
- 2 citations
Original Research
Published on 08 Jan 2024
Characterizing the secretome of EGFR mutant lung adenocarcinoma
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1286821
- 1,829 views
- 1 citation
Original Research
Published on 08 Jan 2024
Incidence of venous thromboembolism and association with PD-L1 expression in advanced non-small cell lung cancer patients treated with first-line chemo-immunotherapy
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1221106
- 1,465 views
- 2 citations
Mini Review
Published on 08 Jan 2024
Vats lobectomy for lung cancer. What has been the evolution over the time?
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1268362
- 1,740 views
- 4 citations
Editorial
Published on 05 Jan 2024
Editorial: World lung cancer awareness month 2022: artificial intelligence for clinical management of lung cancer
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1351016
- 1,307 views
- 1 citation
Perspective
Published on 22 Dec 2023
Treating patients with platinum-sensitive extensive-stage small-cell lung cancer in a real-world setting
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1161931
- 3,828 views
Original Research
Published on 19 Dec 2023
Clinical and molecular profiling of EGFR-mutant lung adenocarcinomas transformation to small cell lung cancer during TKI treatment
in Thoracic Oncology
Frontiers in Oncology
doi 10.3389/fonc.2023.1308313
- 1,797 views
- 2 citations